Antibodies against benzo
Aim: To evaluate the production of antibodies against benzo[a]pyrene (BF) (Ab1) and corresponding antiidiotypic antibodies (AM) in mice after immunization with BP-protein conjugate and in lung cancer patients. Materials and Methods: The Ab1 and AM levels were measured by non-competitive ELISA in blo...
Збережено в:
Дата: | 2013 |
---|---|
Автори: | , , , |
Формат: | Стаття |
Мова: | English |
Опубліковано: |
Інститут експериментальної патології, онкології і радіобіології ім. Р.Є. Кавецького НАН України
2013
|
Назва видання: | Experimental Oncology |
Теми: | |
Онлайн доступ: | http://dspace.nbuv.gov.ua/handle/123456789/145239 |
Теги: |
Додати тег
Немає тегів, Будьте першим, хто поставить тег для цього запису!
|
Назва журналу: | Digital Library of Periodicals of National Academy of Sciences of Ukraine |
Цитувати: | Antibodies against benzo / V.A. Ustinov, V.A. Matveeva, M.A. Kostyanko, A.N. Glushkov // Experimental Oncology. — 2013. — Т. 35, № 3. — С. 207-210. — Бібліогр.: 16 назв. — англ. |
Репозитарії
Digital Library of Periodicals of National Academy of Sciences of Ukraineid |
irk-123456789-145239 |
---|---|
record_format |
dspace |
spelling |
irk-123456789-1452392019-01-20T01:23:26Z Antibodies against benzo Ustinov, V.A. Matveeva, V.A. Kostyanko, M.A. Glushkov, A.N. Original contributions Aim: To evaluate the production of antibodies against benzo[a]pyrene (BF) (Ab1) and corresponding antiidiotypic antibodies (AM) in mice after immunization with BP-protein conjugate and in lung cancer patients. Materials and Methods: The Ab1 and AM levels were measured by non-competitive ELISA in blood serum of 10 mice immunized with BP-protein conjugate, and in blood serum of 288 healthy persons and 165 lung cancer patients. Results: The Ab] level of was 2-fold higher than Ab2 level in blood serum of BP-immunized mice. In lung cancer patients the Ab1 level was almost 3 times higher and the Ab2 level was by 30% higher than these indexes in healthy individuals. The Ab1/Ab2 ratio was 2 in BP-immunized mice and healthy individuals and l in lung cancer patients. Conclusion: Our data have shown that the Ab1/Ab2 ratio in lung cancer patients differ from that in healthy individuals and is close to the Ab1/Ab2 ratio in BP-immunized mouse. Key Words: benzo[a]pyrene, antibodies, lung cancer. 2013 Article Antibodies against benzo / V.A. Ustinov, V.A. Matveeva, M.A. Kostyanko, A.N. Glushkov // Experimental Oncology. — 2013. — Т. 35, № 3. — С. 207-210. — Бібліогр.: 16 назв. — англ. 1812-9269 http://dspace.nbuv.gov.ua/handle/123456789/145239 en Experimental Oncology Інститут експериментальної патології, онкології і радіобіології ім. Р.Є. Кавецького НАН України |
institution |
Digital Library of Periodicals of National Academy of Sciences of Ukraine |
collection |
DSpace DC |
language |
English |
topic |
Original contributions Original contributions |
spellingShingle |
Original contributions Original contributions Ustinov, V.A. Matveeva, V.A. Kostyanko, M.A. Glushkov, A.N. Antibodies against benzo Experimental Oncology |
description |
Aim: To evaluate the production of antibodies against benzo[a]pyrene (BF) (Ab1) and corresponding antiidiotypic antibodies (AM) in mice after immunization with BP-protein conjugate and in lung cancer patients. Materials and Methods: The Ab1 and AM levels were measured by non-competitive ELISA in blood serum of 10 mice immunized with BP-protein conjugate, and in blood serum of 288 healthy persons and 165 lung cancer patients. Results: The Ab] level of was 2-fold higher than Ab2 level in blood serum of BP-immunized mice. In lung cancer patients the Ab1 level was almost 3 times higher and the Ab2 level was by 30% higher than these indexes in healthy individuals. The Ab1/Ab2 ratio was 2 in BP-immunized mice and healthy individuals and l in lung cancer patients. Conclusion: Our data have shown that the Ab1/Ab2 ratio in lung cancer patients differ from that in healthy individuals and is close to the Ab1/Ab2 ratio in BP-immunized mouse. Key Words: benzo[a]pyrene, antibodies, lung cancer. |
format |
Article |
author |
Ustinov, V.A. Matveeva, V.A. Kostyanko, M.A. Glushkov, A.N. |
author_facet |
Ustinov, V.A. Matveeva, V.A. Kostyanko, M.A. Glushkov, A.N. |
author_sort |
Ustinov, V.A. |
title |
Antibodies against benzo |
title_short |
Antibodies against benzo |
title_full |
Antibodies against benzo |
title_fullStr |
Antibodies against benzo |
title_full_unstemmed |
Antibodies against benzo |
title_sort |
antibodies against benzo |
publisher |
Інститут експериментальної патології, онкології і радіобіології ім. Р.Є. Кавецького НАН України |
publishDate |
2013 |
topic_facet |
Original contributions |
url |
http://dspace.nbuv.gov.ua/handle/123456789/145239 |
citation_txt |
Antibodies against benzo / V.A. Ustinov, V.A. Matveeva, M.A. Kostyanko, A.N. Glushkov // Experimental Oncology. — 2013. — Т. 35, № 3. — С. 207-210. — Бібліогр.: 16 назв. — англ. |
series |
Experimental Oncology |
work_keys_str_mv |
AT ustinovva antibodiesagainstbenzo AT matveevava antibodiesagainstbenzo AT kostyankoma antibodiesagainstbenzo AT glushkovan antibodiesagainstbenzo |
first_indexed |
2023-05-20T17:21:37Z |
last_indexed |
2023-05-20T17:21:37Z |
_version_ |
1796153117931208704 |